Incyte | INCY - Market Capitalization

Stock Price
97.10
Daily Change
1.16 1.21%
Monthly
-2.95%
Yearly
36.51%
Q1 Forecast
93.04

Incyte reported $21.4B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Acadia Pharmaceuticals USD 4.52B 919M Dec/2025
Agenus USD 40M 24M Mar/2025
Agios Pharmaceuticals USD 1.59B 745M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amgen USD 176.25B 24.32B Dec/2025
BioCryst Pharmaceuticals USD 1.56B 14M Dec/2024
Biogen USD 25.82B 5.28B Dec/2025
BioMarin Pharmaceutical USD 11.76B 348M Mar/2026
Bristol-Myers Squibb USD 109.81B 18.01B Dec/2025
Eli Lilly USD 1.02T 293.84B Dec/2025
Exelixis USD 11.75B 959M Dec/2025
Gilead Sciences USD 152.28B 14.55B Dec/2025
Incyte USD 19.39B 2.83B Dec/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
MacroGenics USD 106M 29M Sep/2025
Merck USD 261.26B 51.62B Dec/2025
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Novartis USD 265.66B 9.48B Sep/2025
Novartis USD 246.07B 11.81B Sep/2025
Pfizer USD 141.57B 6.48B Dec/2025
PTC Therapeutics USD 6.1B 1.22B Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Sarepta Therapeutics USD 2.26B 238M Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025